42459-12-1

Basic information

• Product Name: 5'-cyanonicotine
• Synonyms: 5'-cyanonicotine
• CAS NO: 42459-12-1
• Molecular Formula: C11H13N3
• Molecular Weight: 187.24102
• Mol File: 42459-12-1.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 336.3°Cat760mmHg
• Flash Point: 157.2°C
• Appearance: /
• Density: 1.13g/cm³
• Vapor Pressure: 0.000113mmHg at 25°C
• Refractive Index: 1.571
• CAS DataBase Reference: 5'-cyanonicotine(CAS DataBase Reference)
• NIST Chemistry Reference: 5'-cyanonicotine(42459-12-1)
• EPA Substance Registry System: 5'-cyanonicotine(42459-12-1)

Safety Data

• Hazardous Substances Data: 42459-12-1(Hazardous Substances Data)

Usage

InChI:InChI=1/C11H13N3/c1-14-10(7-12)4-5-11(14)9-3-2-6-13-8-9/h2-3,6,8,10-11H,4-5H2,1H3

Upstream product

• 486-56-6 cotinine 
• 7677-24-9 trimethylsilyl cyanide 
• 22083-74-5 3-(1-methyl-pyrrolidin-2-yl)-pyridine 
• 54-11-5 nicotin 
• 29419-54-3 nicotine-1'-N-oxide 
• 773837-37-9 sodium cyanide 
• 25162-00-9 D-nicotine 
• 151-50-8 potassium cyanide 
• 1009088-33-8 (S)-1-Methyl-5-pyridin-3-yl-pyrrolidin-2-ol 
• 143-33-9 sodium cyanide 
• 105120-32-9 (S)-nicotine-5'(E)-d1 

Downstream Products

• 71014-67-0 (S)-nicotine Δ-^1',5'-iminium bisperchlorate 

Relevant articles and documents

Letter: Nicotine chemistry. 5'-cyanonicotine.

-

TiO2Nanoparticles Functionalized with Non-innocent Ligands Allow Oxidative Photocyanation of Amines with Visible/Near-Infrared Photons

Photosynthesis is an efficient mechanism for converting solar light energy into chemical energy. We report on a strategy for the aerobic photocyanation of tertiary amines with visible and near-infrared (NIR) light. Panchromatic sensitization was achieved

NICOTINE COMPOUNDS AND ANALOGS THEREOF, SYNTHETIC METHODS OF MAKING COMPOUNDS, AND METHODS OF USE

Embodiments of the present disclosure provide for compounds such as those shown in FIG. 1.1 (compounds A, B, C, and D), 2'substituted nicotine compounds, azetidine compounds, ether linked nicotine compounds (FIG. 1.2, compounds E, F, G, and H), methods of synthesis of the compounds, methods of treatment of a condition using compounds A, B, C, D, 2'substituted nicotine compounds, azetidine compounds, or ether linked nicotine compounds, methods of selectively stimulating alpha7 nAChR and/or alpha4beta2 receptors, and the like.